Center for Psychiatry and Behavioral Medicine. Inc.

Las Vegas, Nevada 89128

0 studies enrolling now · 58 studies all time

What they study most

ADHD, ADHD - Combined Type, ADHD Specifically With Executive Function Impairment, Adult Attention Deficit Hyperactivity Disorder, Anxiety, Separation, Attention Deficit Disorder With Hyperactivity, Attention Deficit Hyper Activity, Attention Deficit Hyperactivity Disorder, Attention Deficit Hyperactivity Disorder (ADHD), Attention Deficit Hyperactivity Disorder Combined, Attention Deficit/Hyperactivity Disorder, Attention-Deficit Hyperactivity Disorder (ADHD)

Studies at this site

A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD — Completed
A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD) — Completed
Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301 — Completed
ADZENYS XR-ODT™ in Children (4 to <6 Years) Diagnosed With Attention-deficit/Hyperactivity Disorder — Withdrawn before enrolling
An Efficacy and Safety Study w/ Azstarys® in Children 4-12 Years of Age With ADHD — Completed
A Study to Evaluate ARD-501 in Patients With Autism Spectrum Disorder — Completed
Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder for Subjects That Have Completed Participation in 331-201-00148 — Completed
Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD — Completed
Ecopipam Tablets to Study Tourette Syndrome in Children and Adolescents - Open Label Extension — Completed
Study to Evaluate Safety & Efficacy of d-Amphetamine Transdermal System vs Placebo in Children & Adolescents With ADHD — Completed
Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents — Completed
Software Treatment for Actively Reducing Severity of ADHD in Adolescents (STARS-ADHD-Adolescents) — Completed
Software Treatment for Actively Reducing Severity of ADHD in Adults (STARS ADHD Adult) — Completed
A Flexible-Dose Titration Study of Aptensio XR in Children Ages 4 to Under 6 Years Diagnosed With ADHD — Completed
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD — Completed
The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder — Completed
A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Classroom Setting — Completed
A Study of Delayed and Extended Release Formulation of Dextroamphetamine Sulfate (HLD100) in Children With ADHD — Completed
KP415 Open-Label Safety Study in Children (6-12 Years of Age) With ADHD — Completed
A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD — Completed
KP415 Classroom Study in Children (6-12 Years of Age) With ADHD — Completed
Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl — Completed
Safety and Efficacy of SPD465 in Adults With ADHD — Completed
Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder — Completed
Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) — Completed
Vyvanse Adolescent Open-Label Safety and Efficacy Extension Study — Completed
Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) — Completed
Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate — Completed
SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP) — Completed
Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) — Completed
Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study) — Completed
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder — Completed
SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder — Completed
Safety and Efficacy of SPD489 in Adolescent Subjects Aged 13-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) — Withdrawn before enrolling
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD) — Completed
Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD — Completed
Dasotraline Pediatric ADHD Study — Completed
TRI102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD) — Completed
Crossover Study to Evaluate the Efficacy of AR11 in Pediatric Patients With ADHD in a Laboratory Classroom Setting — Completed
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years Old With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting. — Completed
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting. — Completed
Dasotraline Pediatric Extension Study — Completed
The Efficacy and Safety of PRC-063 in Adult ADHD Patients — Completed
Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia — Completed
Open-label Safety Study in Adults With ADHD — Completed
Reference Database Development for the Quotient® System iPad Test — Completed
A 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD — Status unconfirmed
PEARL Schizophrenia Maintenance — Completed
Lurasidone Pediatric Autism Study — Completed
NWP09 in Children With Attention Deficit Hyperactivity Disorder (ADHD) — Completed